Lithium Hydroxide → 5-[cis-3,5-Dimethyl-1-piperazinyl]-3-pyridinecarboxylic acid
Reaktionsgleichung
[CH3:1][C@H:2]1[NH:7][C@@H:6]([CH3:8])[CH2:5][N:4]([C:9]2[CH:10]=[C:11]([C:15]([O:17]CC)=[O:16])[CH:12]=[N:13][CH:14]=2)[CH2:3]1.[OH-].[Li+]>O1CCCC1>[CH3:8][C@H:6]1[NH:7][C@@H:2]([CH3:1])[CH2:3][N:4]([C:9]2[CH:10]=[C:11]([C:15]([OH:17])=[O:16])[CH:12]=[N:13][CH:14]=2)[CH2:5]1Komponenten
4
Edukt 2
Produkt 1
Reagenzien, Katalysatoren, Lösungsmittel 1
Versuchsvorschrift
A solution of ethyl 5-[(3R,5S)-3,5-dimethyl-1-piperazinyl]-3-pyridinecarboxylate (D32) (800 mg, 3 mmol) in tetrahydrofuran (5 ml) was treated with 0.5M lithium hydroxide (12 ml, 6 mmol). The mixture was stirred at room temperature for 2 hours. The reaction was quenched with acetic acid (1 ml). The solvent was evaporated and the residue purified on SCX eluting with 2M ammonia in methanol to give the title compound (D33). MS (ES+) m/e 236 [M+H]+.
Aufarbeitung
- customThe reaction was quenched with acetic acid (1 ml)
- customThe solvent was evaporated
- customthe residue purified on SCX
- washeluting with 2M ammonia in methanol
Quellen und Nachweise
- ORD-Eintrag
- ord-47e7385d00a8420ea36b40ab580a86e5
- Quelldatensatz
- uspto-grants-2010_05
- Patentnummer
- US07713978B2
Notizen zur Reaktion
Wird geladen…